← All indications
Niemann-Pick Disease, Type C
An autosomal recessive lipid storage disorder that is characterized by accumulation of CHOLESTEROL and SPHINGOMYELINS in cells of the VISCERA and the CENTRAL NERVOUS SYSTEM. Type C (or C1) and type D are allelic disorders caused by mutation of the NPC1 gene, which encodes a protein that mediates intracellular cholesterol transport from LYSOSOMES. Clinical signs include hepatosplenomegaly and chronic neurological symptoms. Type D is a variant in people with a Nova Scotia ancestry.
Drugs by status
Approved for this indication (3)
Phase 3 trials (3)
Phase 2 trials (6)
Organizations
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (13)
- Cyclotherapeutics
- National Institutes of Health (NIH)
- National Human Genome Research Institute (NHGRI)
- Cornell University
- Duke University
- Johns Hopkins University
- University of Louisville
- Columbia University
- Jiao Tong University
- Salford Royal Foundation NHS Trust
- University of Oxford
- Washington University in St. Louis
- IntraBio Inc
Organization Involved with Phase 1 Indications (4)